Cargando…

Neutralising antibodies in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b.

In a study of 29 patients who were receiving or had received interferon alpha 2b (IFN-alpha 2b) as maintenance therapy for multiple myeloma, antibodies were detected in 58% (17/29) of patients measured by a solid-phase enzyme-linked immunosorbent assay (ELISA). Only 7/17 patients who were positive f...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, J. B., Barfoot, R., Iveson, T., Powles, R. L., Millar, B. C.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033398/
https://www.ncbi.nlm.nih.gov/pubmed/7917911